Ultimovacs ASA (ULTI) — Financial Flexibility Index
Ultimovacs ASA (ULTI) has a Financial Flexibility Index of -0.74x as of December 2024. Free cash flow of Nkr-24.70 Million (operating CF Nkr-24.70 Million minus capex Nkr0.00) represents -1% of total liabilities (Nkr33.19 Million). Check ULTI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ultimovacs ASA Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Ultimovacs ASA across 9 annual periods. See Ultimovacs ASA short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ultimovacs ASA (2016–2024)
Year-by-year free cash flow to debt coverage for Ultimovacs ASA. For the full company profile including market capitalisation, see ULTI company net worth.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.92x | Nkr-163.39 Million | Nkr-163.40 Million | Nkr33.19 Million | ▼ -80.6% |
| 2023 | -2.73x | Nkr-189.80 Million | Nkr-189.83 Million | Nkr69.65 Million | ▲ +1.9% |
| 2022 | -2.78x | Nkr-167.50 Million | Nkr-167.69 Million | Nkr60.32 Million | ▼ -37.8% |
| 2021 | -2.02x | Nkr-125.74 Million | Nkr-125.83 Million | Nkr62.38 Million | ▲ +22.8% |
| 2020 | -2.61x | Nkr-107.94 Million | Nkr-108.22 Million | Nkr41.34 Million | ▼ -38.9% |
| 2019 | -1.88x | Nkr-62.82 Million | Nkr-62.99 Million | Nkr33.41 Million | ▼ -12.9% |
| 2018 | -1.66x | Nkr-49.88 Million | Nkr-50.39 Million | Nkr29.96 Million | ▲ +24.4% |
| 2017 | -2.20x | Nkr-27.20 Million | Nkr-27.23 Million | Nkr12.35 Million | ▲ +50.5% |
| 2016 | -4.45x | Nkr-30.31 Million | Nkr-31.10 Million | Nkr6.81 Million | — |